Postdoc in Precision Immunology/Genomics

Organization
Icahn School of Medicine at Mount Sinai
Job Location
1425 Madison Avenue
New York, NY 10029
Benefits

Full benefits (e.g., health, dental, etc.)

Job Description

The Laserson lab is a new lab focused on developing novel high-throughput
technologies for precision immunology. We utilize next-generation sequencing,
synthetic biology, and single-cell methods to build platform technologies.
Application areas include personalized immunotherapy, gut-immune system
interaction, and therapeutic antibody discovery. We are focused on developing
practical tools that others can build on and that will translate clinically.

The PI

Uri was born in Tel Aviv and grew up in Miami before studying Math and Biology
during college at NYU. He entered the PhD program in the Math department at
MIT, after which he joined George Church’s lab at Harvard Med to train in
genomics technology development. Uri developed some of the first protocols and
software for next-generation sequencing of the antibody repertoire. He also
collaborated with Ben Larman to help develop the PhIP-seq assay for high-
throughput antigen specificity. During graduate school, Uri cofounded Good
Start Genetics, one of the first diagnostics companies to bring NGS to the
clinic. After earning his PhD, Uri worked at Cloudera, which builds Hadoop
infrastructure for big data. During this time, he became a core member of the
ADAM team developing software for scaling genomics analyses to millions of
samples. In 2016, Uri joined the genetics faculty at Mt Sinai.

The Job

You will be a founding member of the lab. Together with the PI, you will be
responsible for defining your research plan and executing it. Research
directions are flexible, but example areas of interest include developing PhIP-
seq-style assays for gut-immune interaction (like IgA-seq), single-cell
phenotyping with NGS, methods for discovering personalized antibody
therapeutics, highly-multiplexed immunohistochemistry. We expect the research
program to require proficiency in a variety of experimental techniques,
including sample/library prep for sequencing, molecular cloning, tissue
culture, antibody assays, and flow cytometry/FACS. Because the lab is new, you
will have the opportunity to help build out a new research lab and will also be
instrumental in defining the lab culture. You can also assist in
training/mentoring graduate students.

And You Are...

We will be utilizing a broad range of cutting-edge techniques, and a
willingness to learn and experiment will be crucial. You should have a PhD or
equivalent experience in a life sciences field. In addition to the techniques
listed above, experience with any of the following would be a plus:

* protein surface display (e.g., phage, yeast, or ribosome display)
* genome editing techniques (e.g., CRISPR)
* synthetic DNA constructs and large oligonucleotide pools
* droplet microfluidics
* single cell methods
* microbiome techniques
* histology/microscopy

How to Apply

Email the PI and include a resume.

About Our Organization

At the Icahn Institute and Department of Genetics and Genomic Sciences at Mount
Sinai, our research and clinical teams work together to translate research
insights to improve patient diagnostics and treatment. The Icahn Institute was
founded in 2011 to help advance precision medicine with cutting-edge
technologies, novel partnerships between the public and private sector, and
world class computational and analytical resources. The Department of Genetics
and Genomic Sciences conducts basic research, trains fellows, and educates the
next generation of doctors and genetic counselors. We are the home of Mount
Sinai’s state-of-the-art genetic testing lab and medical genetics clinic.

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.